Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience.

Delineation of the gastrointestinal tract in magnetic resonance imaging (MRI) remains a problem. Ferric ammonium citrate is paramagnetic, producing a high MRI signal intensity by virtue of its spin-lattice (T1) relaxation rate enhancement properties. Water is diamagnetic, producing a low MRI signal intensity, especially with short TR and TE times. To compare efficacy for gastrointestinal contrast alteration, ferric ammonium citrate was administered to 18 patients and water was given to 10 patients. Spin-echo imaging at 0.35T was performed after administration of these agents. Ferric ammonium citrate produced high signal intensity within the esophagus, stomach, duodenum, and small intestine that aided in the differentiation of the gastrointestinal tract from adjacent tumors, vessels, and viscera. Delineation of the gut wall was superior using ferric ammonium citrate compared to that produced by water. Delineation of the margins of the pancreas, liver, and kidney from adjacent gastrointestinal tract was also better with ferric ammonium citrate. Optimal distinction between bowel and fat was better with water. Longer TE times (75 to 200 ms) may allow improved contrast between gut and intrabdominal fat using ferric ammonium citrate.

[1]  L. Crooks,et al.  Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions. , 1983, Radiology.

[2]  N M Bass,et al.  Chronic liver disease: evaluation by magnetic resonance. , 1984, Radiology.

[3]  H. Goldberg,et al.  Magnetic resonance and CT of the normal and diseased pancreas: a comparative study. , 1984, Radiology.

[4]  Translational molecular self-diffusion in magnetic resonance imaging. I. Effects on observed spin-spin relaxation. , 1984, Investigative radiology.

[5]  L. Hallberg,et al.  Absorbability of different iron compounds. , 2009, Acta medica Scandinavica. Supplementum.

[6]  M. L. Wood,et al.  MR image artifacts from periodic motion. , 1985, Medical physics.

[7]  J Hoenninger,et al.  Nuclear magnetic resonance whole-body imager operating at 3.5 KGauss. , 1982, Radiology.

[8]  L. Kaufman,et al.  Hepatic tumors: magnetic resonance and CT appearance. , 1984, Radiology.

[9]  V M Runge,et al.  Respiratory gating in magnetic resonance imaging at 0.5 Tesla. , 1984, Radiology.

[10]  R. Alfidi,et al.  The effect of motion on two-dimensional Fourier transformation magnetic resonance images. , 1984, Radiology.

[11]  R. Go,et al.  Nuclear Magnetic Resonance (NMR) Imaging in the Evaluation of the Liver: A Preliminary Experience , 1983, Journal of computer assisted tomography.

[12]  H. Hricak,et al.  Clinical nuclear magnetic resonance imaging of the body. , 1983, Seminars in nuclear medicine.

[13]  A. Alavi,et al.  NMR imaging of the abdomen at 0.12 T: initial clinical experience with a resistive magnet. , 1983, AJR. American journal of roentgenology.

[14]  R. G. Stewart,et al.  Work in progress: potential oral and intravenous paramagnetic NMR contrast agents. , 1983, Radiology.

[15]  E. Buonocore,et al.  NMR imaging of the abdomen: technical considerations. , 1983, AJR. American journal of roentgenology.

[16]  C. Partain,et al.  Paramagnetic agents for contrast-enhanced NMR imaging: a review. , 1983, AJR. American journal of roentgenology.